Tuesday, June 19, 2018

AAHS: The real toxic aluminium in vaccines!

In Merck’s Dirty Little SecretDr. Suzanne Humphries wonders why Gardasil hits the immune systems of some of these teenagers so ‘viciously,’
“By Merck’s own admission for every 100,000 people who use Gardasil or Gardasil 9 you expect a minimum of 2300 serious adverse events to combat 12 potential cases of cervical cancer.”
A vial of Gardasil contains AAHS or amorphous aluminium hydroxyphospate sulphate chosen because it ‘binds better to the protein antigen and promotes a bigger immune system bonfire with more antibodies.’
Dr. Humphries states that although she always knew that no child can be standardized, she used to believe that vaccines could be, and claims that we cannot be sure that what is printed on the vaccine label matches what is actually in the vaccine.
Dr. Humphries explains the research done by Shirodkar in 1990 in which the whole-cell DPT vaccine label manufactured by Connaught Laboratories listed the adjuvant as ‘aluminium potassium sulphate’ but was really ‘amorphous aluminium hydroxyphosphate sulphate’ or AAHS, the same adjuvant used in Gardasil.
The diptheria and tetanus toxoids that make up the highly problematic whole cell diptheria, pertussis and tetanus vaccines contain the same adjuvant AAHS as is used today in Gardasil.
Could it be that the aluminium might have played a role in the reactions said to be because of the pertussis endotoxin in the whole cell DPT vaccines? Interestingly, there were many reactions in children who were given just the diptheria and tetanus toxoid vaccines. These vaccines did not contain the pertussis endotoxin.

More Dirty Secrets

A New Zealand hepatitis B package insert from 1987 states that the adjuvant used was aluminium hydroxide. However the labelling was wrong and had to be changed to amorphous aluminium hydroxyphosphate meaning that the hepatitis B vaccines were mislabeled for more than a decade and in reality, contained a more reactive adjuvant and one that was difficult to standardize.
Another example was the misspelling of New Zealand’s VAQTA or the Hepatitis A vaccine.  The 1994 package stated that it contained aluminium hydroxide. However this was incorrect with Merck requesting the label be changed to reflect that the vaccine contained amorphous aluminium hydroxyphospate sulphate or AAHS.  And remember these adjuvants react differently in the body so it is vital that labels are  correct.
We now know that Merck’s vaccines have always contained AAHS in them.
For decades these labels have been incorrect.
Dr. Humphries explains an important implication and one that nullifies the Cochrane Review into aluminium.
In 2004 a Cochrane review of aluminium was undertaken and published in The Lancet,
“We found no evidence that aluminium salts in vaccines cause any serious or long-lasting adverse events. Despite a lack of good-quality evidence we do not recommend that any further research on this topic is undertaken.”
But as Dr. Humphries points out, these reviews were performed on aluminium hydroxide or aluminium phosphate where in reality the vaccines contained amorphous aluminium hydroxyphosphate sulphate or AAHS.
“The fact is that by 2004 vaccine manufacturers knew full well that the labelling was false and never informed.”
– Dr. Thomas Jefferson
 http://australiannationalreview.com/2018/06/17/one-vaccine-vial-is-not-necessarily-the-same-as-the-next/?inf_contact_key=c10caeb81792d64e32409c6b9203bd101a2d501c08f49c612a0d9833508bb85d

No comments: